Evrysdi Unione Europea - italiano - EMA (European Medicines Agency)

evrysdi

roche registration gmbh  - risdiplam - atrofia muscolare, spinale - altri farmaci per i disturbi del sistema muscolo-scheletrico - evrysdi is indicated for the treatment of 5q spinal muscular atrophy (sma) in patients with a clinical diagnosis of sma type 1, type 2 or type 3 or with one to four smn2 copies.